ReviewInternational journal of molecular and cellular medicine2025
Enhancing Osteogenesis in Dental Implants: ZNF710-AS1 and miR-146a-5p in Smad Signaling Pathway Activation.
Review in International journal of molecular and cellular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regulation of Osteoblast Differentiation by miR-214 and miR-206 Through EphrinA2 Signaling: Emerging Therapeutic Insights in Orthodontic Tooth Movement.International journal of molecular and cellular medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Investigations have shown that understanding the regulatory mechanisms of the osteogenic differentiation of periodontal ligament stem cells (PDLSCs) can significantly enhance the regenerative capacity of periodontal tissues and mitigate periodontal disorders. Improving osteogenesis in dental implants is complex, requiring better bone regeneration and integration with the implant surface. ZNF710-AS1 is identified as a key regulator of osteogenic differentiation via the BMP6/Smad pathway, with the overexpression of miR-146a-5p and miR-146b-5p inhibiting ZNF710-AS1's osteogenic effects. This study explores the role of the long noncoding RNA ZNF710-AS1 in PDLSC osteogenic differentiation and clarifies its molecular mechanisms. Results indicate that ZNF710-AS1 expression positively influences osteogenic differentiation, while miR-146a-5p has a suppressive effect. ZNF710-AS1 serves as a competing endogenous RNA (ceRNA) for miR-146a-5p, increasing BMP6 levels and activating the Smad signaling pathway. The study also highlights the role of miR-146a-5p in osteogenesis and inflammation in peri-implant tissues. Findings suggest miR-146a-5p promotes osteogenic differentiation and could be a potential biomarker for periodontal conditions. In summary, this research provided key insights into the molecular mechanisms of osteogenesis and advocates for targeting ZNF710-AS1 and miR-146a-5p to improve dental implant integration and regenerative strategies for periodontal tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.